Variant report

Variant	esv3343864
Chromosome Location	chr16:81812151-81814049
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:330)
CpG islands
(count:427)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:330 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:81812290-81812455	K562	blood:	n/a	n/a
2	ATF2	chr16:81813257-81813585	GM12878	blood:	n/a	n/a
3	ATF3	chr16:81812752-81813041	H1-hESC	embryonic stem cell:	n/a	chr16:81812856-81812876 chr16:81812754-81812763
4	ATF3	chr16:81812752-81812969	GM12878	blood:	n/a	chr16:81812856-81812876 chr16:81812754-81812763
5	ATF3	chr16:81812646-81813043	GM12878	blood:	n/a	chr16:81812856-81812876 chr16:81812754-81812763
6	ATF3	chr16:81812700-81813020	K562	blood:	n/a	chr16:81812856-81812876 chr16:81812754-81812763
7	BACH1	chr16:81813254-81813652	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr16:81813517-81813630	K562	blood:	n/a	n/a
9	BCL3	chr16:81812419-81812895	A549	lung:	n/a	chr16:81812632-81812641
10	BHLHE40	chr16:81813359-81813510	K562	blood:	n/a	n/a
11	BHLHE40	chr16:81812545-81813116	K562	blood:	n/a	chr16:81812903-81812919
12	BHLHE40	chr16:81812593-81813593	GM12878	blood:	n/a	chr16:81812903-81812919
13	BHLHE40	chr16:81813880-81814327	GM12878	blood:	n/a	n/a
14	BHLHE40	chr16:81812217-81812265	K562	blood:	n/a	n/a
15	CBX3	chr16:81812727-81813034	K562	blood:	n/a	n/a
16	CCNT2	chr16:81812569-81813491	K562	blood:	n/a	n/a
17	CEBPB	chr16:81812097-81812436	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr16:81812568-81812617	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD1	chr16:81812922-81814034	GM12878	blood:	n/a	chr16:81813754-81813764
20	CHD2	chr16:81812586-81813014	Hela-S3	cervix:	n/a	n/a
21	CHD2	chr16:81812620-81812776	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD2	chr16:81813467-81813504	K562	blood:	n/a	n/a
23	CHD2	chr16:81813335-81813625	GM12878	blood:	n/a	n/a
24	CHD2	chr16:81812721-81812744	K562	blood:	n/a	n/a
25	CHD2	chr16:81812731-81813058	GM12878	blood:	n/a	n/a
26	CREB1	chr16:81812583-81813058	A549	lung:	n/a	chr16:81812865-81812878
27	CTBP2	chr16:81812564-81813310	H1-hESC	embryonic stem cell:	n/a	n/a
28	CTCF	chr16:81812828-81812939	GM19239	blood:	n/a	n/a
29	CTCF	chr16:81813411-81813548	MCF-7	breast:	n/a	n/a
30	CTCF	chr16:81813540-81813690	GM12872	blood:	n/a	n/a
31	CTCF	chr16:81813380-81813530	HMEC	breast:	n/a	n/a
32	CTCF	chr16:81813527-81813530	GM19238	blood:	n/a	n/a
33	CTCF	chr16:81813513-81813538	GM12891	blood:	n/a	n/a
34	CTCF	chr16:81813350-81813574	GM12878	blood:	n/a	n/a
35	CTCF	chr16:81813360-81813510	GM12871	blood:	n/a	n/a
36	CTCF	chr16:81813360-81813552	GM19240	blood:	n/a	n/a
37	CTCF	chr16:81813460-81813610	GM12873	blood:	n/a	n/a
38	CTCF	chr16:81813660-81813810	GM06990	blood:	n/a	n/a
39	CTCF	chr16:81813340-81813490	GM12870	blood:	n/a	n/a
40	CTCF	chr16:81813480-81813630	Caco-2	colon:	n/a	n/a
41	CTCF	chr16:81813380-81813530	MCF-7	breast:	n/a	n/a
42	CTCF	chr16:81813480-81813630	GM12864	blood:	n/a	n/a
43	CTCF	chr16:81812920-81813070	GM12873	blood:	n/a	n/a
44	CTCF	chr16:81813558-81813627	GM19240	blood:	n/a	n/a
45	CTCF	chr16:81813340-81813490	K562	blood:	n/a	n/a
46	CTCF	chr16:81813460-81813610	GM12869	blood:	n/a	n/a
47	CTCF	chr16:81813479-81813508	GM12891	blood:	n/a	n/a
48	CTCF	chr16:81812740-81813042	GM12878	blood:	n/a	n/a
49	CTCF	chr16:81812881-81812965	GM12891	blood:	n/a	n/a
50	CTCF	chr16:81813440-81813590	GM12868	blood:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:81812606-81812656	GM12892	blood:	n/a
2	chr16:81812565-81812615	GM12891	blood:	n/a
3	chr16:81813969-81814019	LNCaP	prostate:	n/a
4	chr16:81812606-81812656	ovcar-3	ovarian:	n/a
5	chr16:81812606-81812656	SK-N-SH	brain:	n/a
6	chr16:81813969-81814019	Jurkat	blood:	n/a
7	chr16:81813363-81813413	Caco-2	colon:	n/a
8	chr16:81812606-81812656	Hela-S3	cervix:	n/a
9	chr16:81813969-81814019	AG04450	lung:	fetal
10	chr16:81812565-81812615	HAEpiC	amniotic membrane:	n/a
11	chr16:81813706-81813756	MCF10A-Er-Src	breast:	n/a
12	chr16:81813706-81813756	LNCaP	prostate:	n/a
13	chr16:81813969-81814019	A549	lung:	n/a
14	chr16:81813706-81813756	GM12878	blood:	n/a
15	chr16:81813363-81813413	GM12892	blood:	n/a
16	chr16:81812606-81812656	T-47D	breast:	n/a
17	chr16:81812565-81812615	NT2-D1	testis:	n/a
18	chr16:81812738-81812788	HPAEpiC	pulmonary alveolar:	n/a
19	chr16:81812719-81812769	Jurkat	blood:	n/a
20	chr16:81813363-81813413	H1-hESC	embryonic stem cell:	embryo
21	chr16:81813363-81813413	GM12891	blood:	n/a
22	chr16:81812606-81812656	AG04449	skin:	fetal
23	chr16:81813969-81814019	NHDF-neo	bronchial:	n/a
24	chr16:81812606-81812656	H1-hESC	embryonic stem cell:	embryo
25	chr16:81812738-81812788	Caco-2	colon:	n/a
26	chr16:81813706-81813756	HepG2	liver:	n/a
27	chr16:81812565-81812615	ECC-1	luminal epithelium:	n/a
28	chr16:81812565-81812615	HCPEpiC	choroid plexus:	n/a
29	chr16:81812738-81812788	U87	brain:	n/a
30	chr16:81813363-81813413	HUVEC	blood vessel:	n/a
31	chr16:81812565-81812615	SAEC	small airway:	n/a
32	chr16:81813706-81813756	AG04449	skin:	fetal
33	chr16:81812738-81812788	SK-N-SH_RA	brain:	n/a
34	chr16:81812565-81812615	RPTEC	kidney:	n/a
35	chr16:81813969-81814019	HEK293	kidney:	embryo
36	chr16:81813706-81813756	SAEC	small airway:	n/a
37	chr16:81813969-81814019	ProgFib	skin:	n/a
38	chr16:81812719-81812769	MCF10A-Er-Src	breast:	n/a
39	chr16:81813363-81813413	HPAEpiC	pulmonary alveolar:	n/a
40	chr16:81812565-81812615	GM12892	blood:	n/a
41	chr16:81812565-81812615	AG09319	gingival:	n/a
42	chr16:81813706-81813756	RPTEC	kidney:	n/a
43	chr16:81813706-81813756	HRPEpiC	eye:	n/a
44	chr16:81813706-81813756	SK-N-SH_RA	brain:	n/a
45	chr16:81812606-81812656	HRE	kidney:	n/a
46	chr16:81813706-81813756	SK-N-MC	brain:	n/a
47	chr16:81813706-81813756	AoSMC	blood vessel:	n/a
48	chr16:81812606-81812656	RPTEC	kidney:	n/a
49	chr16:81813969-81814019	RPTEC	kidney:	n/a
50	chr16:81812738-81812788	MCF-7	breast:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr16:81811097..81813033-chr16:81817790..81820555,3	MCF-7	breast:
2	chr16:81812978..81813631-chr16:81907214..81907808,2	K562	blood:

No data

Variant related genes	Relation type
PLCG2	TF binding region
PLCG2	CpG island
ENSG00000197943	chromatin interactions

Extended variants
information (count: 102 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:102 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs529009734	chr16:81812161-81812162	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs550386012	chr16:81812174-81812175	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs568873414	chr16:81812187-81812188	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs188641980	chr16:81812200-81812201	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs368032114	chr16:81812203-81812204	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs113211084	chr16:81812204-81812205	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs78596582	chr16:81812206-81812207	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs533803101	chr16:81812218-81812219	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs564890749	chr16:81812220-81812221	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs4273032	chr16:81812236-81812237	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs76594819	chr16:81812255-81812256	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs4500720	chr16:81812275-81812276	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs548978200	chr16:81812285-81812286	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs181110012	chr16:81812316-81812317	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs112787227	chr16:81812348-81812349	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs532393171	chr16:81812352-81812353	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs575642644	chr16:81812373-81812374	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs4401042	chr16:81812392-81812393	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs564436587	chr16:81812397-81812398	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs4496135	chr16:81812407-81812408	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs5818351	chr16:81812420-81812421	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs35131099	chr16:81812421-81812422	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs58759555	chr16:81812435-81812436	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs200931278	chr16:81812436-81812437	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs540904234	chr16:81812487-81812488	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs562300419	chr16:81812513-81812514	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs375128499	chr16:81812545-81812546	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs4511521	chr16:81812552-81812553	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs571411081	chr16:81812562-81812563	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs62046428	chr16:81812566-81812567	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs185209849	chr16:81812591-81812592	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs149216298	chr16:81812640-81812641	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs36096723	chr16:81812703-81812704	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs567114075	chr16:81812712-81812713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs558605468	chr16:81812714-81812715	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs536165318	chr16:81812727-81812728	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs3935647	chr16:81812771-81812772	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs146913733	chr16:81812772-81812773	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs548851651	chr16:81812795-81812796	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs567495272	chr16:81812834-81812835	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs537642709	chr16:81812844-81812845	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs556280078	chr16:81812888-81812889	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs575661815	chr16:81812898-81812899	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs539909468	chr16:81812912-81812913	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs558209120	chr16:81812918-81812919	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs573256971	chr16:81812956-81812957	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs540965735	chr16:81812962-81812963	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs556091955	chr16:81812978-81812979	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs574227095	chr16:81813019-81813020	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs62046429	chr16:81813060-81813061	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Obesity	20622171	CNVD
Cancer	20164920	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16461572	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD

Chromatin state (count:351 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:81792000-81812200	Weak transcription	Right Atrium	heart
2	chr16:81807200-81812200	Weak transcription	Adipose Nuclei	Adipose
3	chr16:81807600-81812400	Weak transcription	Left Ventricle	heart
4	chr16:81808800-81812400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr16:81809600-81812200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr16:81810200-81812200	Weak transcription	GM12878-XiMat	blood
7	chr16:81810400-81812200	Weak transcription	Placenta	Placenta
8	chr16:81811600-81812200	Enhancers	Primary B cells from cord blood	blood
9	chr16:81811800-81812400	Enhancers	Primary B cells from peripheral blood	blood
10	chr16:81811800-81812400	Enhancers	Primary hematopoietic stem cells short term culture	blood
11	chr16:81811800-81812400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
12	chr16:81811800-81813400	Active TSS	K562	blood
13	chr16:81812000-81812200	Weak transcription	Primary monocytes fromperipheralblood	blood
14	chr16:81812000-81812200	Enhancers	Primary hematopoietic stem cells	blood
15	chr16:81812000-81812200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr16:81812000-81812200	Enhancers	Fetal Thymus	thymus
17	chr16:81812000-81812400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
18	chr16:81812000-81812400	Bivalent Enhancer	Fetal Intestine Large	intestine
19	chr16:81812000-81812400	Flanking Active TSS	A549	lung
20	chr16:81812000-81812400	Flanking Active TSS	Hela-S3	cervix
21	chr16:81812000-81812600	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr16:81812000-81812600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
23	chr16:81812000-81812600	Bivalent Enhancer	Stomach Mucosa	stomach
24	chr16:81812000-81813200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
25	chr16:81812000-81814000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
26	chr16:81812200-81812400	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr16:81812200-81812400	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr16:81812200-81812400	Enhancers	Primary monocytes fromperipheralblood	blood
29	chr16:81812200-81812400	Enhancers	Primary T cells from cord blood	blood
30	chr16:81812200-81812400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
31	chr16:81812200-81812400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
32	chr16:81812200-81812400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
33	chr16:81812200-81812400	Enhancers	Duodenum Smooth Muscle	Duodenum
34	chr16:81812200-81812400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
35	chr16:81812200-81812400	Bivalent Enhancer	Fetal Intestine Small	intestine
36	chr16:81812200-81812400	Enhancers	Placenta	Placenta
37	chr16:81812200-81812400	Bivalent Enhancer	Fetal Thymus	thymus
38	chr16:81812200-81812400	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
39	chr16:81812200-81812400	Enhancers	Right Atrium	heart
40	chr16:81812200-81812400	Bivalent Enhancer	Thymus	Thymus
41	chr16:81812200-81812400	Flanking Active TSS	GM12878-XiMat	blood
42	chr16:81812200-81812400	Flanking Active TSS	HMEC	breast
43	chr16:81812200-81812400	Flanking Active TSS	HUVEC	blood vessel
44	chr16:81812200-81812600	Flanking Active TSS	Primary B cells from cord blood	blood
45	chr16:81812200-81812600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
46	chr16:81812200-81812600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr16:81812200-81812600	Enhancers	Esophagus	oesophagus
48	chr16:81812200-81812600	Enhancers	Sigmoid Colon	Sigmoid Colon
49	chr16:81812200-81812600	Enhancers	Small Intestine	intestine
50	chr16:81812200-81812600	Enhancers	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links